Inhalation anesthetics – Halothane MCQs With Answer
Halothane is a classic inhalation anesthetic studied in anesthesia pharmacology for its potency, pharmacokinetics, and unique adverse effects. This concise introduction helps B. Pharm students understand halothane’s mechanism of action, high blood solubility leading to slow induction and recovery, hepatic metabolism producing reactive metabolites, and risks such as halothane hepatitis and cardiac sensitization. Key keywords included are inhalation anesthetics, halothane, B. Pharm, anesthesia pharmacology, hepatotoxicity, metabolism, MAC, and blood-gas partition coefficient. The following 50 carefully designed MCQs with answers will reinforce concepts needed for exams and practical understanding. Now let’s test your knowledge with 50 MCQs on this topic.
Q1. Which of the following best describes halothane’s primary clinical property?
- Highly potent volatile anesthetic with relatively slow induction and recovery
- Low potency agent with rapid induction and recovery
- Intravenous anesthetic used for total intravenous anesthesia
- Short-acting opioid analgesic
Correct Answer: Highly potent volatile anesthetic with relatively slow induction and recovery
Q2. What is the approximate MAC (minimum alveolar concentration) of halothane in adults?
- 0.75%
- 2.5%
- 1.5%
- 3.0%
Correct Answer: 0.75%
Q3. Which property explains halothane’s relatively slow induction compared to newer agents?
- High blood-gas partition coefficient
- High vapor pressure
- High MAC value
- High lipid insolubility
Correct Answer: High blood-gas partition coefficient
Q4. The blood-gas partition coefficient of halothane is best described as:
- Relatively high (~2.0–3.0), promoting slower onset
- Very low (<0.5), promoting rapid onset
- Approximately equal to 1.0
- Negligible because halothane is not blood soluble
Correct Answer: Relatively high (~2.0–3.0), promoting slower onset
Q5. Which statement about halothane and airway irritation is correct?
- Halothane is relatively non-irritant and suitable for inhalation induction
- Halothane is a strong airway irritant and not used for inhalation induction
- Halothane always causes severe bronchospasm
- Halothane is contraindicated in patients with reactive airway disease because it increases secretions
Correct Answer: Halothane is relatively non-irritant and suitable for inhalation induction
Q6. Halothane exerts its anesthetic effect primarily by:
- Modulating neuronal ion channels, including potentiation of GABA-A and inhibition of NMDA receptors
- Directly blocking acetylcholine receptors at the neuromuscular junction
- Acting as an opioid receptor agonist
- Inhibiting monoamine oxidase in the brain
Correct Answer: Modulating neuronal ion channels, including potentiation of GABA-A and inhibition of NMDA receptors
Q7. Which of the following cardiovascular effects is commonly associated with halothane?
- Myocardial depression with decreased cardiac output and blood pressure
- Marked increase in cardiac output and hypertension
- No significant cardiovascular effects
- Only peripheral vasoconstriction without myocardial effects
Correct Answer: Myocardial depression with decreased cardiac output and blood pressure
Q8. Halothane can sensitize the myocardium to catecholamines causing:
- Increased risk of ventricular arrhythmias
- Protection against ischemic arrhythmias
- Improved myocardial contractility with adrenaline
- Complete blockade of beta-adrenergic receptors
Correct Answer: Increased risk of ventricular arrhythmias
Q9. Which complication is specifically associated with halothane metabolism in the liver?
- Halothane hepatitis (immune-mediated severe hepatic necrosis)
- Acute pancreatitis
- Renal tubular necrosis from fluoride ions
- Pulmonary fibrosis
Correct Answer: Halothane hepatitis (immune-mediated severe hepatic necrosis)
Q10. The major pathway of halothane metabolism occurs in the:
- Liver via cytochrome P450 enzymes (e.g., CYP2E1)
- Kidney via renally excreted conjugation
- Plasma via ester hydrolysis
- Brain via oxidative deamination
Correct Answer: Liver via cytochrome P450 enzymes (e.g., CYP2E1)
Q11. A reactive metabolite implicated in halothane hepatitis is:
- Trifluoroacetic acid (TFA)-protein adducts
- Acetylsalicylic acid
- Formaldehyde
- Benzoic acid conjugates
Correct Answer: Trifluoroacetic acid (TFA)-protein adducts
Q12. Halothane-induced hepatitis is most likely after:
- Repeated exposures to halothane, especially in adults
- A single low-dose exposure in infants
- Topical application to skin
- Use of halothane with nitrous oxide only
Correct Answer: Repeated exposures to halothane, especially in adults
Q13. Halothane’s elimination from the body primarily occurs by:
- Exhalation via the lungs
- Renal excretion of unchanged drug
- Complete hepatic metabolism to CO2 and water
- Sequestration in adipose tissue with no elimination
Correct Answer: Exhalation via the lungs
Q14. Compared with newer volatile agents like sevoflurane, halothane is:
- More hepatotoxic and more soluble in blood
- Less hepatotoxic and less soluble
- Non-metabolized and rapidly eliminated
- Safer in malignant hyperthermia
Correct Answer: More hepatotoxic and more soluble in blood
Q15. Which patient factor increases the risk of halothane hepatitis?
- Prior exposure to halothane within months to years
- Use of halothane only once in childhood
- Concomitant use of local anesthetics only
- Exclusive renal impairment without hepatic disease
Correct Answer: Prior exposure to halothane within months to years
Q16. Halothane is classified chemically as:
- A halogenated hydrocarbon anesthetic (2-bromo-2-chloro-1,1,1-trifluoroethane)
- An ether (diethyl ether derivative)
- An organophosphate compound
- A benzodiazepine derivative
Correct Answer: A halogenated hydrocarbon anesthetic (2-bromo-2-chloro-1,1,1-trifluoroethane)
Q17. Which enzyme family metabolizes halothane leading to reactive intermediates?
- Cytochrome P450 (CYP), especially CYP2E1
- Acetylcholinesterase
- Carboxylesterases
- Monoamine oxidase
Correct Answer: Cytochrome P450 (CYP), especially CYP2E1
Q18. In the context of malignant hyperthermia (MH), halothane is considered:
- A known trigger capable of provoking MH in susceptible individuals
- Completely safe and protective against MH
- Unrelated to MH because it is not a volatile agent
- Only a trigger when combined with local anesthetics
Correct Answer: A known trigger capable of provoking MH in susceptible individuals
Q19. Which monitoring parameter is especially important when using halothane due to potential myocardial depression?
- Continuous ECG and blood pressure monitoring
- Urine output without cardiovascular monitoring
- Only pulse oximetry, no ECG required
- Serum glucose monitoring predominantly
Correct Answer: Continuous ECG and blood pressure monitoring
Q20. Which statement about halothane and respiratory effects is correct?
- Halothane causes dose-dependent respiratory depression and decreased tidal volume
- Halothane stimulates respiration and increases tidal volume
- Halothane has no effect on respiratory drive
- Halothane improves respiratory mucociliary clearance
Correct Answer: Halothane causes dose-dependent respiratory depression and decreased tidal volume
Q21. Which organ system is most often monitored for delayed toxicity after halothane anesthesia?
- Liver function (transaminases)
- Bone marrow function
- Cerebrospinal fluid composition
- Pancreatic enzymes
Correct Answer: Liver function (transaminases)
Q22. A distinguishing laboratory finding in halothane hepatitis is:
- Marked elevation of serum transaminases and signs of hepatic necrosis
- Isolated hyperbilirubinemia without transaminase change
- Marked leukocytosis only
- Raised creatine kinase with normal liver tests
Correct Answer: Marked elevation of serum transaminases and signs of hepatic necrosis
Q23. Which preoperative history is most relevant to consider before using halothane?
- Previous severe reaction to halothane or prior halothane exposure with hepatitis
- History of seasonal allergies only
- Remote minor allergic reactions to penicillin without hepatic issues
- Orthopedic surgery many years ago with no complications
Correct Answer: Previous severe reaction to halothane or prior halothane exposure with hepatitis
Q24. Halothane’s analgesic properties are:
- Limited; it primarily provides unconsciousness and some immobility, analgesia is modest
- Strong, equivalent to morphine
- Absent; halothane provides sedation only
- Exclusive to peripheral nerve blockade
Correct Answer: Limited; it primarily provides unconsciousness and some immobility, analgesia is modest
Q25. Which of the following best explains why halothane is less favored in modern anesthesia practice?
- Risk of severe hepatotoxicity and slower pharmacokinetics compared with newer agents
- It is too inexpensive and widely available
- It provides insufficient depth of anesthesia at any concentration
- It cannot be vaporized for delivery
Correct Answer: Risk of severe hepatotoxicity and slower pharmacokinetics compared with newer agents
Q26. Interaction of halothane with succinylcholine increases the risk of:
- Malignant hyperthermia and hyperkalemia in susceptible patients
- Renal failure due to nephrotoxicity
- Immediate anaphylaxis in all patients
- Prolonged neuromuscular blockade without metabolic effects
Correct Answer: Malignant hyperthermia and hyperkalemia in susceptible patients
Q27. Halothane’s effect on intracranial pressure (ICP) is generally:
- To increase ICP by causing cerebral vasodilation at high concentrations
- To markedly decrease ICP in all patients
- No influence on cerebral blood flow
- To produce cerebral vasoconstriction and reduced CBF
Correct Answer: To increase ICP by causing cerebral vasodilation at high concentrations
Q28. Which lab test could be useful postoperatively if halothane hepatitis is suspected?
- Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST)
- Serum amylase alone
- Serum potassium only
- Serum magnesium exclusively
Correct Answer: Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST)
Q29. Which of the following describes halothane’s effect on uterine smooth muscle?
- Halothane causes uterine relaxation and can increase bleeding at high doses
- Halothane causes strong uterine contraction
- Halothane has no effect on the uterus
- Halothane is contraindicated in pregnancy due to teratogenicity
Correct Answer: Halothane causes uterine relaxation and can increase bleeding at high doses
Q30. In pediatric anesthesia, halothane was historically used because it is:
- Non-irritant to the airway and suitable for inhalational induction in children
- Extremely rapid with immediate recovery
- Associated with no hepatic metabolism in children
- Incapable of causing cardiovascular depression in children
Correct Answer: Non-irritant to the airway and suitable for inhalational induction in children
Q31. Which statement about halothane storage and handling is correct?
- Halothane is nonflammable but should be stored properly to avoid contamination and degradation
- Halothane is highly flammable and must be kept away from all heat sources
- Halothane cannot be vaporized and should be stored in a freezer
- Halothane should be mixed with oxygen before storage
Correct Answer: Halothane is nonflammable but should be stored properly to avoid contamination and degradation
Q32. Which metabolic consequence of halothane is associated with potential renal effects in some older volatile anesthetics but less so with halothane?
- Release of inorganic fluoride ions (less prominent with halothane than some others)
- High levels of unmetabolized ethers in urine
- Polyol accumulation causing osmotic diuresis
- Massive proteinuria directly caused by halothane
Correct Answer: Release of inorganic fluoride ions (less prominent with halothane than some others)
Q33. Which of the following practices reduces the risk of halothane-related liver injury?
- Avoiding repeated exposures and using alternative agents when possible
- Increasing halothane concentration to shorten exposure time
- Administering halothane only with acetaminophen
- Using halothane in patients with known prior halothane hepatitis
Correct Answer: Avoiding repeated exposures and using alternative agents when possible
Q34. Which pharmacokinetic factor contributes to slower recovery from halothane anesthesia?
- High solubility in blood and tissues leading to larger uptake
- Rapid hepatic clearance with no tissue uptake
- Complete renal excretion of unchanged drug
- Immediate metabolism to water-soluble metabolites
Correct Answer: High solubility in blood and tissues leading to larger uptake
Q35. Which monitoring device helps assess adequacy of inhalational anesthesia depth during halothane use?
- End-tidal anesthetic gas concentration monitoring (ET halothane)
- Urine output measurement alone
- Serial blood halothane levels hourly
- Noninvasive blood glucose monitoring
Correct Answer: End-tidal anesthetic gas concentration monitoring (ET halothane)
Q36. Compared with isoflurane, halothane is generally:
- More soluble in blood and more likely to cause myocardial depression
- Less soluble and less cardiodepressive
- More expensive and entirely synthetic opioid
- Completely devoid of hepatic metabolism
Correct Answer: More soluble in blood and more likely to cause myocardial depression
Q37. If a patient develops severe hyperpyrexia and muscle rigidity after halothane and succinylcholine, the immediate management should include:
- Administration of dantrolene and supportive measures for malignant hyperthermia
- Immediate infusion of high-dose glucose only
- Administration of naloxone
- Immediate peritoneal dialysis
Correct Answer: Administration of dantrolene and supportive measures for malignant hyperthermia
Q38. Which clinical sign could suggest halothane sensitization of the heart?
- Ventricular arrhythmias after administration of epinephrine
- Bradycardia that responds only to atropine
- Asystole immediately on induction in all patients
- Isolated ST depressions without rhythm change
Correct Answer: Ventricular arrhythmias after administration of epinephrine
Q39. The chemical formula of halothane is correctly written as:
- C2HBrClF3 (2-bromo-2-chloro-1,1,1-trifluoroethane)
- C4H10O (butyl ether)
- C2H5Cl (ethyl chloride)
- C3H7F (propyl fluoride)
Correct Answer: C2HBrClF3 (2-bromo-2-chloro-1,1,1-trifluoroethane)
Q40. In terms of occupational exposure for staff, halothane requires:
- Scavenging systems to minimize environmental exposure
- No precautions because it is non-toxic to staff
- Only handwashing precautions with no air handling
- Use of lead aprons to prevent inhalation
Correct Answer: Scavenging systems to minimize environmental exposure
Q41. Halothane produces immobility primarily by action at the:
- Spinal cord (ventral horn inhibition of motor neurons)
- Peripheral neuromuscular junction blocking acetylcholine release
- Cerebellum exclusively
- Peripheral nociceptors only
Correct Answer: Spinal cord (ventral horn inhibition of motor neurons)
Q42. Which of the following is true regarding halothane and pediatric hepatotoxicity?
- Severe halothane hepatitis is less common in young children than adults
- Children are at the highest risk of halothane hepatitis compared with adults
- Hepatitis occurs only if halothane is given with NSAIDs
- Hepatotoxicity is universal after a single pediatric exposure
Correct Answer: Severe halothane hepatitis is less common in young children than adults
Q43. Which inhalational anesthetic property contributes most to potency (low MAC)?
- High lipid solubility of the agent
- High vapor pressure only
- Low blood solubility exclusively
- High degree of renal excretion
Correct Answer: High lipid solubility of the agent
Q44. A patient with known prior severe halothane hepatitis should be managed by:
- Avoiding halothane and selecting alternative modern volatile agents
- Using halothane with prophylactic corticosteroids only
- Giving halothane in lower doses multiple times to build tolerance
- Proceeding with halothane if liver tests are normal on the day of surgery
Correct Answer: Avoiding halothane and selecting alternative modern volatile agents
Q45. Which of the following best characterizes halothane’s impact on renal blood flow?
- Generally reduces renal blood flow due to systemic hypotension and cardiac depression
- Markedly increases renal blood flow through renal vasodilation
- No effect on renal circulation in any dose
- Directly causes renal artery thrombosis
Correct Answer: Generally reduces renal blood flow due to systemic hypotension and cardiac depression
Q46. In comparing recovery profiles, halothane recovery is usually slower than sevoflurane because:
- Halothane has higher blood and tissue solubility leading to greater uptake and storage
- Halothane is rapidly metabolized to inactive water-soluble compounds
- Sevoflurane is not eliminated via the lungs
- Halothane is administered intravenously only
Correct Answer: Halothane has higher blood and tissue solubility leading to greater uptake and storage
Q47. Which feature made halothane attractive historically for pediatric induction?
- Pleasant odor and minimal airway irritation
- High MAC leading to weak anesthesia
- Rapid metabolism preventing accumulation
- Absolute lack of any cardiac effects
Correct Answer: Pleasant odor and minimal airway irritation
Q48. The diagnosis of halothane hepatitis is primarily based on:
- Clinical presentation of jaundice, malaise, elevated transaminases and recent halothane exposure
- Urine ketone positivity and normal liver enzymes
- Exclusive rise in serum amylase without hepatic signs
- Positive blood culture for halothane
Correct Answer: Clinical presentation of jaundice, malaise, elevated transaminases and recent halothane exposure
Q49. Which statement about halothane-induced arrhythmias is correct?
- Arrhythmias are more likely with concurrent catecholamine administration
- Arrhythmias are prevented by epinephrine administration
- Halothane never causes arrhythmias
- Only bradyarrhythmias occur with halothane, never ventricular arrhythmias
Correct Answer: Arrhythmias are more likely with concurrent catecholamine administration
Q50. For examination preparation, which study focus will best help B. Pharm students understand halothane clinically?
- Mechanism of action, pharmacokinetics, hepatic metabolism, adverse effects, and safe clinical use
- Only the chemical synthesis steps without clinical implications
- Exclusive focus on cost analysis and market availability
- Studying halothane as an intravenous agent
Correct Answer: Mechanism of action, pharmacokinetics, hepatic metabolism, adverse effects, and safe clinical use



